We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative New Instrument Could Transform Oral Cancer Diagnosis

By HospiMedica International staff writers
Posted on 20 Feb 2023

Identifying lesions of the mouth (dysplasia) that have the potential to become cancerous can be a difficult task and, as a result, patients may receive unnecessary treatments or have missed cancer diagnoses. More...

Currently, dysplasia is diagnosed by examining tissue samples from patients under a microscope. This process is both time-consuming and can be subject to human error, making it unreliable. Now, an innovative new instrument currently under development could transform oral cancer diagnosis.

A research team from the University of Liverpool (Liverpool, UK) and Liverpool Head & Neck Centre (LHNC; Liverpool, UK) is developing the Liverpool Diagnostic Infrared (LDIR) Wand, a hand-held device that can rapidly and accurately identify lesions in the mouth that will develop into cancer. The LDIR wand uses a small number of infrared lasers, combined with machine learning algorithm analysis of infrared spectral images of tissue, to identify the lesions in the mouth that are not currently malignant but will become malignant in the future. The researchers will initially develop a prototype of the LDIR Wand for use in histopathology laboratories that could eventually be used in clinics for real-time diagnostics.

“This instrument addresses a difficult clinical problem in head and neck cancer diagnosis,” said Professor Richard Shaw from the LHNC. “We know that earlier diagnosis is key to saving lives, but predicting cancer risk in oral patches is problematic. For some patients we miss a high risk of cancer developing, but for other patients we cannot safely reassure them without better information”

Related Links:
University of Liverpool
LHNC


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.